---
title: "Zealand Pharma climbs on share buyback program"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285600065.md"
description: "Shares of Zealand Pharma rose approximately 9% after the company announced a share buyback program to repurchase nearly $200M worth of stock over the next five months. The program, managed by Danske Bank, will buy back up to 7.2M shares from May 7 to October 31, 2026. Additionally, Zealand Pharma is set to receive $700M in milestone payments from Roche this year related to its weight loss candidate, petrelintide, including $575M expected in H2 for Phase 3 trials and a $125M anniversary payment in Q2."
datetime: "2026-05-07T18:47:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285600065.md)
  - [en](https://longbridge.com/en/news/285600065.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285600065.md)
---

# Zealand Pharma climbs on share buyback program

Shares of Zealand Pharma (ZLDPF) closed ~9% higher in Denmark after the Danish biotech announced a share buyback program to repurchase nearly $200M (DKK 1.3B) worth of its stock over the next five months. The obesity drug developer has appointed Copenhagen-based Danske Bank as lead manager for the program under which it plans to buy back up to 7.2M...

### Related Stocks

- [RHHBY.US](https://longbridge.com/en/quote/RHHBY.US.md)
- [RHHVF.US](https://longbridge.com/en/quote/RHHVF.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [DNKEY.US](https://longbridge.com/en/quote/DNKEY.US.md)

## Related News & Research

- [FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment | RHHBY Stock News](https://longbridge.com/en/news/286594661.md)
- [Roche, Medicines Patent Pool sign deal to expand access to influenza drug](https://longbridge.com/en/news/286796802.md)
- [Relay drug shows early promise against rare blood vessel diseases](https://longbridge.com/en/news/287094432.md)
- [NeOnc Advances Glioma Programs and Strengthens Financial Position](https://longbridge.com/en/news/286826865.md)
- [<![CDATA[Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates]]>](https://longbridge.com/en/news/286787081.md)